Juvenile Myelomonocytic Leukemia (JMML)

Text Size A A

E-Mail to a Friend

secret  Click to Play Audio

Participate in a Study

Because cancer is rare in children, the medical community has cooperated for many years to investigate new treatments and treatment variations in an effort to identify the most effective and safest possible options. The success in treating pediatric illness is the best example of success through collaboration. In 1960, about 10 to 20 percent of children with cancer survived. Now nearly 85 percent do. Through cooperative efforts such as the Children’s Oncology Group, doctors continue to make significant progress in treatment. Clinical studies are the backbone of this success.

In clinical studies, researchers prescribe promising treatment regimens, monitor the patients’ responses carefully and compare this treatment to standard treatment. More than half of all children with cancer in the United States receive treatment through clinical studies, also called clinical trials.

For an overview of what happens in clinical studies, read our Patient Guide to Clinical Studies, especially the section on Children and Clinical Studies.

To find clinical studies for which your child may be eligible, ask your child’s healthcare team.